From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases
From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases is a paper indexed in ScholarIQ from OpenAlex.
How many citations does From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases have?
From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases has 0 citations in the OpenAlex counts ScholarIQ stores.
When was From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases published?
From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases has 2025 year in the ScholarIQ index.
What is the open-access status of From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases?
From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases has hybrid oa status in the ScholarIQ index.
What is the DOI of From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases?
The DOI for From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases is on the source record.
What is the PMID of From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases?
The PMID for From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases is on the source record.
What is the OpenAlex record for From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases?
The OpenAlex for From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases is on the source record.